We noted a tendency for 1,25-VitD3-treated animals to have fewer MPO+ neutrophils in the brain at 24 h post-stroke, whereas there was no effect on CD3+ T cells (Fig. 6a, b). The gene discussed is MPO; the disease is stroke disorder.